Drug Makers To Prepare For Pharmacovigilance Reforms In Russia And Other EAEU Countries
This article was originally published in SRA
Executive Summary
Drug companies operating in Russia and the other Eurasian Economic Union countries are being advised to prepare for the new obligations and liabilities that an impending new regulation on pharmacovigilance in the EAEU might introduce for them.